XML 33 R22.htm IDEA: XBRL DOCUMENT v3.21.2
Share-Based Compensation
6 Months Ended
Jul. 31, 2021
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share-Based Compensation
Note 14 – Share-Based Compensation
We have one equity incentive plan from which we are authorized to grant equity awards, the AstroNova, Inc. 2018 Equity Incentive Plan (the “2018 Plan”). The 2018 Plan provides for, among other things, the issuance of awards, including incentive stock options,
non-qualified
stock options, stock appreciation rights, time-based restricted stock units (“RSUs”), or performance-based restricted stock units (“PSUs”) and restricted stock awards (RSAs). The 2018 Plan authorizes the issuance of up to 950,000 shares of common stock, plus an additional number of shares equal to the number of shares subject to awards granted under previous equity incentive plans that are forfeited, cancelled, satisfied without the issuance of stock, otherwise terminated (other than by exercise), or, for shares of stock issued pursuant to any unvested award, that are reacquired by us at not more than the grantee’s purchase price (other than by exercise). Under the 2018 Plan, all awards to employees generally have a minimum vesting period of one year. Options granted under the 2018 Plan must be issued at an exercise price of not less than the fair market value of our common stock on the date of grant and expire after ten years. Under the 2018 Plan, there were 133,836 unvested RSUs; 65,167 unvested PSUs; 20,410 unvested RSAs and options to purchase an aggregate of 135,500 shares outstanding as of July 31, 2021.
In addition to the 2018 Plan, we previously granted equity awards under our 2015 Equity Incentive Plan (the “2015 Plan”) and our 2007 Equity Incentive Plan (the “2007 Plan”). No new awards may be issued under either the 2007 or 2015 plans, but outstanding awards will continue to be governed by those plans. As of July 31, 2021, options to purchase an aggregate of 326,968 shares were outstanding under the 2007 Plan and 3,750 unvested shares of restricted stock and options to purchase an aggregate of 141,175 shares were outstanding under the 2015 Plan.
We also have a
Non-Employee
Director Annual Compensation Program (the “Program”), under which each of our
non-employee
directors automatically receives a grant of restricted stock on the date of their
re-election
to our board of directors. The number of whole shares granted is equal to the number calculated by dividing the stock component of the director compensation amount determined by the compensation committee for that year by the fair market value of our stock on that day. The value of the restricted stock award for fiscal 20
22
is $60,000. Shares of restricted stock granted under the Program become vested on the first anniversary of the date of grant, conditioned upon the recipient’s continued service on our board of directors through that date.
Share-based compensation expense was recognized as follows:
 
    
Three Months Ended
    
Six Months Ended
 
(In thousands)
  
July 31,
2021
    
August 1,
2020
    
July 31,
2021
    
August 1,
2020
 
Stock Options
   $ 57      $ 131      $ 162      $ 264  
Restricted Stock Awards and Restricted Stock Units
     408        465        778        822  
Employee Stock Purchase Plan
     4        5        7        10  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ 469      $ 601      $ 947      $ 1,096  
    
 
 
    
 
 
    
 
 
    
 
 
 
Stock Options
There were no stock options granted during the six months ended July 31, 2021 and August 1, 2020.
Aggregated information regarding stock option activity for the six months ended July 31, 2021 is summarized below:
 
    
Number of
Options
    
Weighted Average
Exercise Price
 
Outstanding at January 31, 2021
     622,083      $ 14.63  
Granted
     —          —    
Exercised
     (4,425      9.57  
Forfeited
     (14,015      14.96  
Canceled
     —          —    
    
 
 
    
 
 
 
Outstanding at July 31, 2021
     603,643      $ 14.66  
    
 
 
    
 
 
 
Set forth below is a summary of options outstanding at July 31, 2021:
 
Outstanding
    
Exercisable
 
Range of
Exercise prices
  
Number
of
Option
s
    
Weighted-
Average
Exercise
Price
    
Weighted-
Average
Remaining
Contractual Life
    
Number
of
Option
s
    
Weighted-
Average
Exercise
Price
    
Weighted
Average
Remaining
Contractual
Life
 
$5.00-10.00
     37,244      $ 7.97        1.0        37,244      $ 7.97        1.0  
$10.01-15.00
     348,649      $ 13.62        4.4        336,649      $ 13.61        4.3  
$15.01-20.00
     217,750      $ 17.47        6.3        210,875      $ 17.44        6.3  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
       603,643      $ 14.66        4.9
 
 
     584,768
 
 
   $ 14.63        4.8  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
As of July 31, 2021, there was approximately $59,000 of unrecognized compensation expense related to stock options which is expected to be recognized over a weighted average period of approximately 0.6 years.
Restricted Stock Units (RSUs) and Restricted Stock Awards (RSAs)
Aggregated information regarding RSU and RSA activity for the six months ended July 31, 2021 is summarized below:
 
 
  
RSAs & RSUs
 
  
Weighted Average
Grant Date Fair Value
 
Outstanding at January 31, 2021
     197,413     $ 9.96  
Granted
     147,006       14.43  
Vested
     (121,256     10.30  
    
 
 
   
 
 
 
Outstanding at July 31, 2021
     223,163     $ 12.72  
    
 
 
   
 
 
 
As of July 31, 2021, there was approximately $2.5 million of unrecognized compensation expense related to RSUs and RSAs which is expected to be recognized over a weighted average period of 1.0 year.
Employee Stock Purchase Plan
We have an Employee Stock Purchase Plan allowing eligible employees to purchase shares of common stock at a 15% discount from fair value on the first or last day of an offering period, whichever is less. A total of 247,500 shares were reserved for issuance under this plan. During the six months ended July 31, 2021 and August 1, 2020, there were 3,899 and 8,851 shares, respectively, purchased under this plan. As of July 31, 2021, 6,475 shares remain available for purchase under our Employee Stock Purchase Plan.